Aurobindo Pharma Q3 net loss at Rs 28 cr

摘要

DRUG firm Aurobindo Pharma posted a consolidated net loss of Rs 28.54 crore for the quarter ended December 31, 2011, primarily on account of foreign exchange losses suffered during the quarter.The company had posted a net profit of Rs 188.63 crore for the corresponding period last fiscal, Aurobindo Pharma said in a statement.Net sales of the company rose to Rs 1,284.51 crore In the third quarter ended December 31, 2011, from Rs 1,192.20 In the same period last fiscal.Commenting on the results, Aurobindo Pharma Chairman Ramprasad Reddy said: "The current fiscal year has been challenging on account of full Impact of the USFDA alert on our Unit 6 Cephalosporin manufacturing facility and mark-to-market loss on foreign currency borrowings."